A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Imiquimod (Primary)
- Indications Extramammary Paget disease
- Focus Therapeutic Use
- 05 Feb 2018 Status changed from active, no longer recruiting to completed.
- 29 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 29 Mar 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.